ERBB2 and colorectal carcinoma: This model recapitulates quite well features observed in actual CRC patients, such as the dysregulation of key molecules in CRC metastasis such as CDH17, ERBB2, AIP, IL13Rα2, PTPRN, or MMP7, among others [13,14,15,17,18].